Clinical Trial Update: Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous and oral fosfomycin for hospitalised neonates with clinical sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Fosfomycin (Fosfomycin)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Neonatal SEPSIS | Phase 2 | Status: COMPLETED